NeueHealth, Inc. (NEUE)
(Delayed Data from NYSE)
$5.15 USD
+0.23 (4.71%)
Updated Aug 30, 2024 11:36 AM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Income Statements
Fiscal Year end for NeueHealth, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,161 | 2,412 | 4,029 | 1,207 | 281 |
Cost Of Goods | 997 | 2,206 | 3,954 | 1,047 | 224 |
Gross Profit | 164 | 206 | 76 | 160 | 56 |
Selling & Adminstrative & Depr. & Amort Expenses | 741 | 828 | 1,274 | 418 | 182 |
Income After Depreciation & Amortization | -577 | -622 | -1,198 | -258 | -125 |
Non-Operating Income | -14 | 1 | 1 | 0 | 0 |
Interest Expense | 38 | 13 | 8 | 0 | 0 |
Pretax Income | -629 | -634 | -1,205 | -258 | -125 |
Income Taxes | -1 | 4 | -27 | -9 | 0 |
Minority Interest | -114 | 96 | 7 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -628 | -638 | -1,178 | -248 | -125 |
Extras & Discontinued Operations | -638 | -722 | 0 | 0 | 0 |
Net Income (GAAP) | -1,151 | -1,456 | -1,185 | -248 | -125 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 17 | -447 | -1,163 | -249 | -124 |
Depreciation & Amortization (Cash Flow) | 594 | 175 | 35 | 8 | 1 |
Income After Depreciation & Amortization | -577 | -622 | -1,198 | -258 | -125 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 7.95 | 7.85 | 4.90 | NA | NA |
Diluted EPS Before Non-Recurring Items | -17.62 | -86.40 | -241.60 | NA | NA |
Diluted Net EPS (GAAP) | -150.94 | -190.40 | -241.60 | -145.60 | NA |
Fiscal Year end for NeueHealth, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 225.99 | 245.10 | -162.92 | 269.40 | 297.98 |
Cost Of Goods | 177.68 | 196.87 | -163.53 | 226.44 | 245.16 |
Gross Profit | 48.31 | 48.22 | 0.61 | 42.96 | 52.82 |
SG&A, R&D, and Dept/Amort Expenses | 85.86 | 71.32 | 5.67 | 505.73 | 76.24 |
Income After SG&A, R&D, and Dept/Amort Expenses | -37.55 | -23.10 | -5.06 | -462.77 | -23.42 |
Non-Operating Income | 2.21 | 32.38 | -4.10 | -9.87 | 0.00 |
Interest Expense | 4.11 | 2.93 | 11.21 | 10.04 | 9.17 |
Pretax Income | -39.45 | 6.35 | -20.36 | -482.69 | -32.58 |
Income Taxes | -0.19 | 0.66 | 1.59 | -3.39 | -0.89 |
Minority Interest | 0.93 | 11.74 | -230.86 | 86.75 | 24.21 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -39.26 | 5.69 | -21.95 | -479.31 | -31.69 |
Extras & Discontinued Operations | -18.44 | -9.87 | -438.62 | -67.84 | -56.94 |
Net Income (GAAP) | -58.63 | -15.91 | -229.72 | -633.90 | -112.83 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 8.25 | 8.08 | 7.95 | 7.98 | 7.96 |
Diluted EPS Before Non-Recurring Items | -6.42 | -2.31 | 20.07 | -8.31 | -8.55 |
Diluted Net EPS (GAAP) | -8.65 | -3.53 | -30.21 | -81.03 | -15.70 |